Nicholas Investment Partners, LP Legend Biotech Corp Transaction History

Nicholas Investment Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$55.06 - $69.99 $1.14 Million - $1.45 Million	-20,674 Reduced 77.58%	5,976 $335,000
Q4 2023 Feb 07, 2024	SELL	$57.25 - $69.74 $32.4 Million - $39.5 Million	-566,360 Reduced 95.51%	26,650 $1.6 Million
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $9,916 - $12,010	-157 Reduced 0.03%	593,010 $39.8 Million
Q2 2023 Aug 09, 2023	SELL	$46.28 - $75.01 $1.03 Million - $1.66 Million	-22,166 Reduced 3.6%	593,167 $40.9 Million
Q1 2023 May 11, 2023	BUY	$43.42 - $57.37 $9.39 Million - $12.4 Million	216,218 Added 54.17%	615,333 $29.7 Million
Q4 2022 Feb 10, 2023	SELL	$38.8 - $55.46 $14,394 - $20,575	-371 Reduced 0.09%	399,115 $19.9 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $15.2 Million - $22.8 Million	399,486 New	399,486 $16.3 Million

225

74.3M

279K

350K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.49B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.